Immunex/Wyeth Enbrel Launch Price Is $10,400 Per Year
Executive Summary
Immunex is seeking a three-fold price premium for its rheumatoid arthritis therapy Enbrel (etanercept) over the most recent new entry into the class.
You may also be interested in...
Wyeth-Ayerst To Produce Enbrel At Former Glaxo Wellferon Site
Wyeth-Ayerst plans to manufacture the rheumatoid arthritis therapy Enbrel at a West Greenwich, R.I. biopharmaceutical facility purchased from Glaxo.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011